- Home
- ALZN vs VEEE Comparison
ALZN vs VEEE Comparison
Compare ALZN & VEEE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALZN
- VEEE
- Stock Information
- Founded
- ALZN 2016
- VEEE 1994
- Country
- ALZN United States
- VEEE United States
- Employees
- ALZN N/A
- VEEE N/A
- Industry
- ALZN Medicinal Chemicals and Botanical Products
- VEEE Marine Transportation
- Sector
- ALZN Health Care
- VEEE Industrials
- Exchange
- ALZN Nasdaq
- VEEE Nasdaq
- Market Cap
- ALZN 6.1M
- VEEE 6.1M
- IPO Year
- ALZN 2021
- VEEE 2021
- Fundamental
- Price
- ALZN $0.96
- VEEE $0.41
- Analyst Decision
- ALZN Strong Buy
- VEEE
- Analyst Count
- ALZN 1
- VEEE 0
- Target Price
- ALZN $32.00
- VEEE N/A
- AVG Volume (30 Days)
- ALZN 825.5K
- VEEE 135.1K
- Earning Date
- ALZN 03-24-2025
- VEEE 03-25-2025
- Dividend Yield
- ALZN N/A
- VEEE N/A
- EPS Growth
- ALZN N/A
- VEEE N/A
- EPS
- ALZN N/A
- VEEE N/A
- Revenue
- ALZN N/A
- VEEE $20,949,492.00
- Revenue This Year
- ALZN N/A
- VEEE $76.99
- Revenue Next Year
- ALZN N/A
- VEEE N/A
- P/E Ratio
- ALZN N/A
- VEEE N/A
- Revenue Growth
- ALZN N/A
- VEEE N/A
- 52 Week Low
- ALZN $0.92
- VEEE $0.31
- 52 Week High
- ALZN $15.06
- VEEE $1.29
- Technical
- Relative Strength Index (RSI)
- ALZN 26.54
- VEEE 47.95
- Support Level
- ALZN $0.92
- VEEE $0.39
- Resistance Level
- ALZN $1.15
- VEEE $0.43
- Average True Range (ATR)
- ALZN 0.06
- VEEE 0.03
- MACD
- ALZN -0.01
- VEEE -0.00
- Stochastic Oscillator
- ALZN 13.61
- VEEE 30.61
About ALZN Alzamend Neuro Inc.
Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.
About VEEE Twin Vee PowerCats Co.
Twin Vee PowerCats Co is a designer, manufacturer, and marketer of recreational and commercial power catamaran boats to use for fishing, diving and water skiing and commercial activities including transportation, eco-tours, fishing, and diving expeditions. Its revenue is derived from the sale of boats, motors, and trailers to its independent dealers. It has organized its business into three operating segments: The gas-powered boat segment, which manufactures and distributes gas-powered boats; The electric-powered boat segment, which is developing fully electric boats, through its controlling interest subsidiary, and its franchise segment, which is developing a standard product offering and will be selling franchises across the United States through its wholly-owned subsidiary.